AstraZeneca to be exempt from coronavirus vaccine liability claims in most countries
(Reuters) — AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters.
